ATROZEMB
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Sept 2023)
What this means for you
Registered since 21 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86658366
- Registration number
- 5167095
- Mark type
- Stylized text
- Filed
- 10 Jun 2015
- Published for opposition
- 27 Oct 2015
- Registered
- 21 Mar 2017
- Attorney of record
- Brian A. Bloom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, anti-hypercholesterolemia
Owner
- Liptis Pharmaceuticals USA, Inc., Spring Valley, NY, US
- Liptis Pharmaceuticals USA, Inc., Spring Valley, NY, US
- Liptis Pharmaceuticals USA, Inc., Spring Valley, NY, US
Prosecution history
- 21 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 21 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 15 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Jan 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Dec 2016 — USE AMENDMENT FILED
- 17 Jan 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Dec 2016 — TEAS STATEMENT OF USE RECEIVED
- 23 Jun 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2016 — SOU EXTENSION 1 GRANTED